Literature DB >> 27782115

Body mass index and the risk of all-cause mortality among patients with nonvalvular atrial fibrillation: a multicenter prospective observational study in China.

H Wan1,2, S Wu1, J Wang1, Y Yang1, J Zhu1, X Shao1, B Huang1, H Zhang1.   

Abstract

BACKGROUND/
OBJECTIVES: High body mass index (BMI) is associated with increased incident atrial fibrillation (AF) and mortality rate. In patients presenting with nonvalvular AF (NVAF), the prognostic relevance of BMI remains unclear. SUBJECTS/
METHODS: In this prospective observational study, a total of 1759 patients with NVAF (69.9±12.9 years old, 47.9% male) were divided into three clinical settings according to estimated stroke risks (CHADS2 score ⩽1 (low), =2 (moderate) and ⩾3 (high)). The primary outcome was all-cause mortality, and the secondary outcomes included thromboembolism and major bleeding. Cox-proportional hazard models were used to estimate the association between BMI levels and clinical outcomes.
RESULTS: During a mean follow-up of 1 year representing 1974 patient-years at risk, 256 patients died, 142 suffered from thromboembolism and 17 developed major bleeding. Multivariate adjusted Cox analysis indicated that a BMI of 24.0-27.9 kg/m2 was independently associated with improved survival among all patients (hazard ratio (HR) 0.689, 95% confidence interval (CI) 0.512-0.928; P=0.018) and patients at high stroke risk (HR 0.622, 95% CI 0.410-0.943; P=0.024), but not among those at low or moderate stroke risks. No associations were observed between BMI levels and the incidence of thromboembolic events in various clinical settings.
CONCLUSIONS: A paradoxical BMI-all-cause mortality risk association was observed in Chinese patients with NVAF, and this association was pronounced among patients at high stroke risk rather than in those at low stroke risk.

Entities:  

Mesh:

Year:  2016        PMID: 27782115     DOI: 10.1038/ejcn.2016.183

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  38 in total

1.  The guidelines for prevention and control of overweight and obesity in Chinese adults.

Authors:  Chunming Chen; Frank C Lu
Journal:  Biomed Environ Sci       Date:  2004       Impact factor: 3.118

2.  Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation.

Authors:  Deirdre A Lane; Gregory Y H Lip
Journal:  Circulation       Date:  2012-08-14       Impact factor: 29.690

Review 3.  Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants.

Authors:  Pasquale Strazzullo; Lanfranco D'Elia; Giulia Cairella; Francesca Garbagnati; Francesco P Cappuccio; Luca Scalfi
Journal:  Stroke       Date:  2010-03-18       Impact factor: 7.914

4.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Authors:  Stefan D Anker; Abdissa Negassa; Andrew J S Coats; Rizwan Afzal; Philip A Poole-Wilson; Jay N Cohn; Salim Yusuf
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

5.  Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus.

Authors:  Wenhui Zhao; Peter T Katzmarzyk; Ronald Horswell; Yujie Wang; Weiqin Li; Jolene Johnson; Steven B Heymsfield; William T Cefalu; Donna H Ryan; Gang Hu
Journal:  Circulation       Date:  2014-11-05       Impact factor: 29.690

6.  Body mass index and adverse events in patients with incident atrial fibrillation.

Authors:  Thure Filskov Overvad; Lars Hvilsted Rasmussen; Flemming Skjøth; Kim Overvad; Gregory Y H Lip; Torben Bjerregaard Larsen
Journal:  Am J Med       Date:  2013-04-17       Impact factor: 4.965

7.  Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.

Authors:  H Zhang; Y Yang; J Zhu; X Shao; Y Liu; L Zhao; P Yu; H Zhang; Q He; X Gu
Journal:  Intern Med J       Date:  2014-08       Impact factor: 2.048

Review 8.  Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.

Authors:  Carl J Lavie; Martin A Alpert; Ross Arena; Mandeep R Mehra; Richard V Milani; Hector O Ventura
Journal:  JACC Heart Fail       Date:  2013-04-01       Impact factor: 12.035

9.  Obesity paradox: conditioning on disease enhances biases in estimating the mortality risks of obesity.

Authors:  Samuel H Preston; Andrew Stokes
Journal:  Epidemiology       Date:  2014-05       Impact factor: 4.822

10.  The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin.

Authors:  S Goya Wannamethee; A Gerald Shaper; Peter H Whincup; Lucy Lennon; Olia Papacosta; Naveed Sattar
Journal:  Int J Cardiol       Date:  2013-11-23       Impact factor: 4.164

View more
  2 in total

1.  Body mass index and the risk of all-cause mortality among patients with nonvalvular atrial fibrillation: a multicenter prospective observational study in China; methodological issues.

Authors:  N Karamzad; S Safiri
Journal:  Eur J Clin Nutr       Date:  2017-05-03       Impact factor: 4.016

2.  Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation.

Authors:  Yu Zhang; Yi-Qiang Yuan
Journal:  Arq Bras Cardiol       Date:  2021-02       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.